Amlodipine 10mg Drug Use Investigation

• Status: Completed
• Trial end date: 2012-10-01
• Target enrollment: 0
• Participant gender: All

Summary

In this survey, to collect the safety and efficacy information in the subjects who have been treated with amlodipine 5mg at least 4 weeks in daily practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer; Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
• Treatments: Amlodipine

Criteria

Inclusion Criteria:

• Male or female subjects who have been treated with amlodipine 5mg at least 4 weeks

• The subjects who had not achieved target BP

Exclusion Criteria:

• Subjects who have been prescribed amlodipine (Norvasc®) 10mg Tablet before